Appendix 3B
New issue announcement
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement,
application for quotation of additional securities
and agreement
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13
Name of entity
SONIC HEALTHCARE LIMITED
ABN
24 004 196 909
We (the entity) give ASX the following information.
Part 1 - All issues
You must complete the relevant sections (attach sheets if there is not enough space).
- +Class of +securities issued or to be issued
- Number of +securities issued or to be issued (if known) or maximum number which may be issued
Ordinary shares
366,569
3 | Principal | terms | of | the | Fully paid ordinary shares | |
+securities | (e.g. if | options, | ||||
exercise price and expiry date; if | ||||||
partly | paid | +securities, | the | |||
amount | outstanding | and | due | |||
dates | for | payment; | if | |||
+convertible | securities, | the | ||||
conversion price and dates for | ||||||
conversion) | ||||||
+ See chapter 19 for defined terms.
04/03/2013 | Appendix 3B Page 1 |
Appendix 3B
New issue announcement
- Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?
If the additional +securities do not rank equally, please state: - the date from which they do
- the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment
- the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment
- Issue price or consideration
6 Purpose of the issue
(If issued as consideration for the acquisition of assets, clearly identify those assets)
6a Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?
If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i
6b The date the security holder resolution under rule 7.1A was passed
Yes
- 250,069 shares issued at $29.33 per share on the exercise of options with an exercise price of $17.32 per option.
- 5,000 shares issued at $29.33 per share on the exercise of options with an exercise price of $18.84 per option.
- 76,500 shares issued at $29.33 per share on the exercise of options with an exercise price of $19.78 per option
- 35,000 shares issued at $29.33 per share on the exercise of options with an exercise price of $21.62 per option
Exercise of options
No
N/A
+ See chapter 19 for defined terms.
Appendix 3B Page 2 | 04/03/2013 |
Appendix 3B
New issue announcement
6c | Number | of +securities | issued | N/A |
without | security | holder | ||
approval under rule 7.1 | ||||
6d | Number | of +securities | issued | |
N/A | ||||
with security holder approval | ||||
under rule 7.1A | ||||
6e | Number | of +securities | issued | |
N/A | ||||
with security holder approval | ||||
under rule 7.3, or another | ||||
specific security holder approval | ||||
(specify date of meeting) | ||||
6f Number of +securities issued under an exception in rule 7.2
6g If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation.
N/A
N/A
6h | If +securities were issued under | N/A | ||||
rule | 7.1A | for | non‐cash | |||
consideration, state | date | on | ||||
which | valuation | of | ||||
consideration | was released | to | ||||
ASX Market Announcements | ||||||
6i | Calculate the entity's remaining | |||||
N/A | ||||||
issue capacity under rule 7.1 and | ||||||
rule 7.1A - complete Annexure 1 | ||||||
and release to ASX Market | ||||||
Announcements | ||||||
7 | +Issue dates | |||||
10 September 2019 |
Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.
Cross reference: item 33 of Appendix 3B.
+ See chapter 19 for defined terms.
04/03/2013 | Appendix 3B Page 3 |
Appendix 3B
New issue announcement
8 | Number | and +class | of | all | Number | +Class |
474,800,473 | Ordinary | |||||
+securities | quoted | on | ASX | |||
(including the +securities in | ||||||
section 2 if applicable) |
9 Number and +class of all +securities not quoted on ASX (including the +securities in section 2 if applicable)
Number | +Class |
Options Expiring on: | |
26,500 | 30.11.2019 @ $18.84 |
552,500 | 20.08.2020 @ $18.49 |
356,641 | 20.11.2020 @ $19.41 |
1,356,333 | 11.10.2020 @ $19.78 |
725,000 | 17.09.2021 @ $21.62 |
180,000 | 17.09.2021 @ $22.02 |
671,089 | 17.11.2021 @ $21.62 |
950,000 | 05.05.2022 @ $23.34 |
675,145 | 22.11.2022 @ $21.64 |
667,787 | 21.11.2023 @ $21.69 |
2,000,000 | 14.10.2023 @ $21.83 |
980,000 | 21.12.2023 @ $24.30 |
Performance Rights | |
Expiring on: | |
87,843 | 17.11.2021 |
87,762 | 22.11.2022 |
87,560 | 21.11.2023 |
10 | Dividend policy (in the case of a | Same as existing |
trust, distribution policy) on the | ||
increased capital (interests) |
Part 2 - Pro rata issue
11 Is security holder approval N/A required?
12 | Is the issue renounceable or non‐ | N/A |
renounceable? |
13 Ratio in which the +securities N/A will be offered
14 | +Class of +securities to which the | N/A |
offer relates |
+ See chapter 19 for defined terms.
Appendix 3B Page 4 | 04/03/2013 |
Appendix 3B
New issue announcement
15 | +Record date to determine | N/A |
entitlements |
16 Will holdings on different N/A registers (or subregisters) be aggregated for calculating entitlements?
- Policy for deciding entitlements in relation to fractions
- Names of countries in which the entity has security holders who will not be sent new offer documents
Note: Security holders must be told how their entitlements are to be dealt with.
Cross reference: rule 7.7.
N/A
N/A
- Closing date for receipt of acceptances or renunciations
- Names of any underwriters
- Amount of any underwriting fee or commission
- Names of any brokers to the issue
- Fee or commission payable to the broker to the issue
- Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of security holders
- If the issue is contingent on security holders' approval, the date of the meeting
- Date entitlement and acceptance form and offer documents will be sent to persons entitled
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
+ See chapter 19 for defined terms.
04/03/2013 | Appendix 3B Page 5 |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
Sonic Healthcare Limited published this content on 10 September 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 September 2019 06:46:01 UTC